Hemodynamic effects of supplemental oxygen administration in congestive heart failure

Journal of the American College of Cardiology

Volumn 27, Issue 2, 1996, Pages 353-357

  Haque, Wasim A ^c   Boehmer, John ^c   Clemson, Barry S ^c   Leuenberger, Urs A ^c   Silber, David H ^c   Sinoway, Lawrence I ^a,b  

^a AMERICAN HEART ASSOCIATION   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LUNG WEDGE PRESSURE; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0030045137     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00474-2     Document Type: Article

References (21)

1. Smith TW, Braunwald E, Kelly RA. The management of heart failure. In: Braunwald E, editor. Heart Diseases. 4th ed. Philadelphia: Saunders, 1992:464-519.
2. Daly WJ, Bondurant S. Effects of oxygen breathing on the heart rate, blood pressure and cardiac index of normal men-resting, with reactive hyperemia, and after atropine. J Clin Invest 1962;41:126-32.
3. Eggers GWN, Paley HW, Leonard JJ, Warren JV. Hemodynamic responses to oxygen breathing in man. J Appl Physiol 1962;17:75-9.
4. Thomas M, Malmcrona R, Shillingford J. Hemodynamic effects of oxygen in patients with acute myocardial infarction. Br Heart J 1965;27:401-7.
5. Zelis R, Flaim SF. Alteration in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:437-59.
6. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiol Rev 1979;59:919-56.
7. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985;57:461-9.
8. Sinoway LI, Rea RF, Mosher TJ, Smith MB, Mark AL. Hydrogen ion concentration is not the sole determinant of muscle metaboreceptor responses in humans. J Clin Invest 1992;89:1875-84.
9. Seals DR, Suwarno NO, Dempsey JA. Influence of lung volume on sympathetic nerve discharge in normal humans. Circ Res 1990;67:130-41.
10. Seals DR, Johnson DG, Fregosi RF. Hyperoxia lowers sympathetic activity at rest but not during exercise in humans. Am J Physiol 1991;260:873-8.
11. Hardy JC, Gray K, Whisler S, Leuenberger U. Sympathetic and blood pressure responses to voluntary apnea are augmented by hypoxemia. J Appl Physiol 1994;77:2360-5.
12. Godfrey K. Comparing the means of several groups. In: Bailar J, Mosteller F, editors. Medical Uses of Statistics. Waltham, MA: New England Journal of Medicine, 1986.
13. Daniell HB, Bagwell EE. Effects of high oxygen on coronary flow and heart force. Am J Physiol 1968;214:1454-9.
14. 2 consumption and cardiac output during normobaric hyperoxia in conscious dogs. J Appl Physiol 1989;67:1551-9.
15. Reinhart K, Bloos F, Konig F, Bredle D, Hannemann L. Reversible decrease of oxygen consumption by hyperoxia. Chest 1991;99:690-4.
16. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-6.
17. Lee DS, Butzer ML, Creager MA. Nitric oxide mediates hypoxic vasodilation of resistance vessels in humans [abstract]. Circulation 1994;90:I-295.
18. Pohl U, Busse R. Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol 1989;256:H1595-600.
19. Stuart MJ, Yamaja Setty BN, Walenga RW, Graeber JE, Ganley C. Effects of hyperoxia and hypoxia on vascular prostacylcin formation in vitro, Pediatrics 1984;74:548-53.
20. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium derived relaxing factor. Am J Physiol 1986;250:H822-7.
21. Klabunde RE, Ritger RC, Helgren MC. Cardiovascular actions of inhibitors of endothelium derived relaxing factor (nitric oxide) formation/release in anesthestized dogs. Eur J Pharmacol 1991;199:51-9.